This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Robert Jarvik | |
|---|---|
| Name | Robert Jarvik |
| Birth date | 1946-05-11 |
| Birth place | Midland, Michigan |
| Occupation | Medical researcher, inventor |
| Known for | Development of the Jarvik-7 artificial heart |
Robert Jarvik is an American medical researcher and inventor noted for his role in the development of a permanent, pneumatic artificial heart widely known as the Jarvik-7. His work intersected with leading institutions and figures in biomedical engineering, cardiac surgery, and medical device regulation, generating both clinical milestones and public controversies. Jarvik's career spans laboratory research, collaboration with surgeons, interaction with regulatory bodies, and later engagements in public policy and commercial ventures.
Jarvik was born in Midland, Michigan, and raised in a family that moved between Michigan and Connecticut. He completed undergraduate studies at the University of Utah before entering the medical and research training pathways that connected him with prominent institutions such as the University of Utah School of Medicine, the National Institutes of Health, and the Mayo Clinic. During graduate training he worked with investigators affiliated with the American Heart Association and the National Aeronautics and Space Administration on physiological modeling and materials science. His academic mentors included clinicians and researchers associated with cardiothoracic surgery programs at universities like Harvard University and Johns Hopkins University.
Jarvik's early research combined interests in polymer science, hemodynamics, and prosthetic device design, linking laboratories at the University of Utah, the University of Minnesota, and private research groups funded by foundations such as the Rockefeller Foundation and agencies including the National Science Foundation. He collaborated with surgeons and engineers from centers including the Cleveland Clinic, Massachusetts General Hospital, and the University of Pennsylvania. His publications and presentations appeared at meetings organized by the Society of Thoracic Surgeons, the American College of Cardiology, and the European Society of Cardiology, and he engaged with regulatory frameworks administered by the Food and Drug Administration and with ethics committees at institutions such as Yale University.
Jarvik became associated with a multidisciplinary team that included engineers, materials scientists, and notable surgeons such as William DeVries and advisors from programs at the University of Utah and the National Institutes of Health. The device evolved from earlier ventricular assist devices developed at centers like the University of Utah Hospital and borrowed design elements tested in laboratories at the National Heart, Lung, and Blood Institute. Prototypes underwent bench testing and animal studies in facilities connected to Columbia University, Stanford University, and veterinary programs at land-grant institutions. The Jarvik-7 used polyurethane and other biomaterials evaluated by investigators who had published through venues such as the Journal of Thoracic and Cardiovascular Surgery and presented at the International Society for Heart and Lung Transplantation.
Clinical implantation of the device was performed by surgeons including William DeVries at centers such as the University of Utah Hospital and drew attention from media outlets including The New York Times, Time, and Newsweek. Early human use intersected with debates in forums like the American Medical Association and with regulatory review by the Food and Drug Administration. Ethical discussion involved bioethicists affiliated with Harvard Medical School, Georgetown University, and Columbia University, and raised questions debated at conferences sponsored by the National Institutes of Health and the Kennedy Institute of Ethics. Controversies encompassed patient selection reviewed by institutional review boards at institutions such as Johns Hopkins University Hospital and allegations that engaged legal actors including firms in New York and Utah. The device's outcomes influenced practice patterns in cardiac centers like the Cleveland Clinic and shaped subsequent trials coordinated by consortia including the Cardiac Transplantation Society.
After the initial clinical period Jarvik engaged with commercial partners, investors on Wall Street, and medical device companies headquartered in regions such as California and Massachusetts. He participated in public outreach through appearances on networks including NBC, ABC, and PBS, and debated issues at policy forums hosted by organizations like the Heritage Foundation and the Brookings Institution. Jarvik also became involved with advocacy groups focused on cardiovascular disease such as the American Heart Association and participated in technology commercialization efforts with incubators linked to MIT and Stanford University. His public-facing roles drew commentary from medical journals including The Lancet and The Journal of the American Medical Association.
Jarvik's personal life included residence in locations such as Utah and Connecticut and associations with professional societies including the American Society for Artificial Internal Organs and the American Institute for Medical and Biological Engineering. Family connections and private pursuits were occasionally discussed in profiles published by outlets such as The Wall Street Journal and People (magazine), while he maintained ties to alumni networks at the University of Utah and other institutions.
The device linked to Jarvik is preserved in historical narratives at institutions such as the Smithsonian Institution and has been the subject of museum exhibitions and academic case studies at universities including Yale University and Princeton University. Jarvik received recognition from professional societies including awards presented by the American Institute for Medical and Biological Engineering and lectureships at centers such as Columbia University Irving Medical Center and Harvard Medical School. His work influenced subsequent generations of researchers at laboratories in Germany, Japan, and France and helped catalyze regulatory pathways administered by the Food and Drug Administration and clinical programs at institutions such as the Cleveland Clinic and the Mayo Clinic.
Category:1946 births Category:American inventors Category:Medical researchers